Rheumatoid Arthritis

Top Story

Tofacitinib plus methotrexate sustain improvements for 2 years in RA

Tofacitinib plus methotrexate sustain improvements for 2 years in RA
March 25, 2019
In the Journals

Treatment recommendations for RA in cancer fail to meet criteria

March 25, 2019
Treatment recommendations for rheumatoid arthritis among patients with cancer “often fail” to meet expected criteria methodology, and although there is broad…
FDA News

FDA warns Nutra Pharma against 'bogus products' for chronic pain, addiction

March 19, 2019
The FDA has issued a warning letter to Nutra Pharma Corp., ordering the company to cease what it describes as illegal marketing of unapproved homeopathic products that…

Fighting an 'invisible epidemic' during Autoimmune Disease Awareness Month

March 13, 2019
Faced with an increasing incidence and prevalence of autoimmune disease in the United States —approximately 23.5 million Americans are affected across the country…
More Headlines »

Highlights of the Rheumatology Summit: A Master Class in RA, PsA, and SpA

This activity is supported by independent educational grants from AbbVie; Celgene Corporation; Lilly USA, LLC; Merck & Co., Inc.; and Pfizer, Inc.

This CME-certified monograph is specifically designed for health care professionals to advance their knowledge…
More »
Meeting News

Workplace flexibility significantly impacts employment for patients with RA

November 9, 2018
More »

Rheum360: Focus on Biosimilars

This activity is supported by an independent medical education grant from Sandoz Inc., a Novartis Division.

Chronic inflammatory diseases, such as rheumatoid arthritis, psoriasis, psoriatic arthritis, vasculitis, and axial…
More »